Cardiac Pathways seeks approval for heart rhythm treatment:
This article was originally published in Clinica
Executive Summary
Cardiac Pathways has submitted an application for US approval of its cooled ablation system for treating ventricular tachycardia, a dangerously rapid heartbeat. The company is seeking expedited review for the device. The Chilli system works by burning channels in the heart with radiofrequency energy. Small tubes in the catheter deliver saline to cool the catheter tip. The system has been tested in clinical trials at 15 sites in the US involving 159 patients, most of whom had severe heart disease. Some 76% of those treated experienced complete eradication of VT after the procedure.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.